These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33341308)

  • 1. Global production capacity of seasonal and pandemic influenza vaccines in 2019.
    Sparrow E; Wood JG; Chadwick C; Newall AT; Torvaldsen S; Moen A; Torelli G
    Vaccine; 2021 Jan; 39(3):512-520. PubMed ID: 33341308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2015 global production capacity of seasonal and pandemic influenza vaccine.
    McLean KA; Goldin S; Nannei C; Sparrow E; Torelli G
    Vaccine; 2016 Oct; 34(45):5410-5413. PubMed ID: 27531411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
    Nannei C; Goldin S; Torelli G; Fatima H; Kumar K; Bubb-Humfryes O; Stenson B; Sparrow E
    Vaccine; 2016 Oct; 34(45):5393-5399. PubMed ID: 27646029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global production capacity of seasonal influenza vaccine in 2011.
    Partridge J; Kieny MP
    Vaccine; 2013 Jan; 31(5):728-31. PubMed ID: 23149268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A global pandemic influenza vaccine action plan.
    Kieny MP; Costa A; Hombach J; Carrasco P; Pervikov Y; Salisbury D; Greco M; Gust I; LaForce M; Franco-Paredes C; Santos JI; D'Hondt E; Rimmelzwaan G; Karron R; Fukuda K
    Vaccine; 2006 Sep; 24(40-41):6367-70. PubMed ID: 17240560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).
    Palkonyay L; Fatima H
    Vaccine; 2016 Oct; 34(45):5414-5419. PubMed ID: 27498212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Palache A; Rockman S; Taylor B; Akcay M; Billington JK; Barbosa P;
    Vaccine; 2021 Oct; 39(41):6081-6087. PubMed ID: 34521551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
    Grohmann G; Francis DP; Sokhey J; Robertson J
    Vaccine; 2016 Oct; 34(45):5420-5424. PubMed ID: 27506497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic.
    Surichan S; Wirachwong P; Supachaturas W; Utid K; Theerasurakarn S; Langsanam P; Lakornrach P; Nitisaporn L; Chansikkakorn C; Vangkanonta W; Kaweepornpoj R; Poopipatpol K; Thirapakpoomanunt S; Srichainak S; Artavatkun W; Chokevivat V; Wibulpolprasert S
    Vaccine; 2011 Jul; 29 Suppl 1():A29-33. PubMed ID: 21684425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
    Palache A; Abelin A; Hollingsworth R; Cracknell W; Jacobs C; Tsai T; Barbosa P;
    Vaccine; 2017 Aug; 35(36):4681-4686. PubMed ID: 28754488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for broad global access to pandemic influenza vaccines.
    Edwards KM; Sabow A; Pasternak A; Boslego JW
    Curr Top Microbiol Immunol; 2009; 333():471-93. PubMed ID: 19768420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries.
    Monto AS; Black S; Plotkin SA; Orenstein WA
    Vaccine; 2011 Sep; 29(38):6427-31. PubMed ID: 21763381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia.
    Suhardono M; Ugiyadi D; Nurnaeni I; Emelia I
    Vaccine; 2011 Jul; 29 Suppl 1():A22-5. PubMed ID: 21684423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.
    Partridge J; Kieny MP;
    Vaccine; 2010 Jul; 28(30):4709-12. PubMed ID: 20488262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global review of seasonal influenza vaccine introduction: analysis of the WHO/UNICEF Joint Reporting Form.
    Sambala EZ; Ngcobo N; Machingaidze S; Wiyeh AB; Mahasha PW; Jaca A; Cooper S; Wiysonge CS
    Expert Rev Vaccines; 2019 Aug; 18(8):859-865. PubMed ID: 31318303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.